Genpact's 24% Growth Pocket Is Carrying the Story-Q2 Shows the Mix Shift Is Real

Q2 strengthened the case that Genpact's higher-value mix is driving results

Genpact's faster-growing segment is reshaping the investment story, but the market still wants proof. Bulls see it as evidence the company is moving beyond routine services toward higher-value AI-led economics. Skeptics counter that this narrative has appeared before and that a single quarter is not enough to fully change the stock's label.

What makes this quarter notable is that the shift is visible in the numbers, not just in messaging. Q2 revenue was $1.343 billion, up 7.1%. Adjusted EPS reached $1.00, up 13.6%. Advanced Technology Solutions generated $363 million, or 27% of total net revenues, and grew 24.1% year over year.

Management also raised its full-year ATS growth outlook to at least 25% and lifted 2026 adjusted EPS growth guidance to at least 12%. That matters because the higher-value part of the business is becoming large enough to influence the company's overall trajectory. If investors begin to value Genpact for that mix, the stock could trade on a more growth-oriented lens before the full-year print is complete. The next test is whether bookings, backlog, and quarter-by-quarter execution keep pace.

Genpact's business model sits between outsourcing and consulting

The operating logic is straightforward. Genpact is not trying to become a consulting firm from scratch; it is layering higher-value work onto an existing client and contract base.

From headcount-driven services to outcome-based work

Genpact's foundation is familiar: large enterprises hire it to run finance and accounting, procurement, customer service, supply chain operations, risk management, and data and analytics work under long-term contracts. In that model, the client relationship and recurring revenue stream already exist. ATS is less a radical pivot than an upgrade to what is already being delivered.

A body-shop model is close to renting workers: more work usually means more heads, with limited margin leverage. Genpact's middle path is to redesign the process first and then continue running it. That combines workflow improvement advice with ongoing delivery and recurring revenue from long-term relationships. The higher-value piece is not a side project; it is a deeper penetration of processes clients already outsourced.

Why the mix matters for economics

The shift was already underway before the latest buzz. In 2025, Genpact generated $5.080 billion in revenue, while Advanced Technology Solutions reached $1.204 billion, or 24% of revenue, and adjusted diluted EPS rose 11.3%. The higher-value mix was already helping lift the broader business.

This quarter shows the pattern continuing. ATS is now 27% of total net revenues, and Genpact has delivered 13 consecutive quarters of year-over-year gross margin expansion. That is the clearest sign investors care about: the better part of the business is not only growing, it is also supporting the profit profile.

As ATS moves from 24% of revenue to the high-20s, even a modest mix improvement can help earnings power and valuation. Bulls call that the bridge from service company to outcome company. Skeptics will reasonably argue it is still too early to fully relabel the stock. But the mechanism is now visible: existing contracts, deeper solutions, and improving returns.

The debate now is durability, not creativity

This quarter made the transformation story more credible. The remaining question is whether Genpact is undergoing a real mix upgrade or simply enjoying a strong demand cycle within a familiar service model.

Why investors can be constructive

The bullish case is simple: management is not asking investors to trust a vision alone. It is raising the pace. After reporting record bookings, increasing backlog, Genpact now expects Advanced Technology Solutions revenue to grow at least 25% for the full year. If demand, bookings, and execution stay firm, the higher-value segment should become the main engine for the whole company.

Why skeptics still have a case

The cautious view is also reasonable. Genpact still primarily delivers process-heavy work under long-term contracts, including finance and accounting, procurement, customer service, supply chain operations, risk management, and data and analytics work. That means weaker enterprise spending could still slow the advanced mix. Skeptics also have historical precedent: Genpact can sound like an AI-driven company, but if the higher-value business remains a side pocket, the stock may never get fully reclassified.

What to watch over the next few quarters

The next calls will matter most in three areas: - whether revenue guidance holds and growth remains in the current range - whether ATS growth continues to outpace the broader business - whether bookings keep converting into backlog

If any of those signals weaken materially, this may look more like a strong cycle than a durable rerating. For now, the evidence suggests the mix shift is real, but investors still need a few more quarters of confirmation.